Clinical Trial Update: MRG-001 in Patients With Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study of MRG-001 in amyotrophic lateral sclerosis (ALS), which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• MRG-001

Snippet

Sponsor: MedRegen LLC | Conditions: Amyotrophic Lateral Sclerosis, Lou Gehrig Disease | Phase 2 | Status: NOT_YET_RECRUITING